Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 17β-HSD3 inhibitors(hydroxysteroid 17-beta dehydrogenase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hormone-dependent prostate cancer | Preclinical | GB | 01 Feb 2013 |